** Australia-listed shares of Fisher & Paykel Healthcare FPH.AX rise as much as 1.8% to A$31.39
** Morgan Stanley initiates coverage on medical equipment maker, rated 'equal-weight' on stock, price target set at A$34
** Brokerage sees solid earnings growth with favourable long-term outlook, supported by increased clinical adoption
** Brokerage hikes its PT for co's shares in New Zealand FPH.NZ to NZ$36.70 from NZ$36.30, seeing less material U.S. tariff impacts on co
** Fisher & Paykel's NZ shares up 0.3% at NZ$33.55
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。